Home LiteratureArticle Details
PMID: 9109743 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group.

Archives of neurology ·Vol. 54 ·No. 4 ·1997-04-00 ·Pages 416-24

Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I

Abstract

To determine if mortality is increased in individuals with human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders less severe than frank dementia. A prospective cohort study; median duration of follow-up was 2.4 years. Kaplan-Meier analysis and Cox proportional hazards models were used to compare survival times according to neurocognitive classification. University-based research unit. A volunteer sample of 414 individuals seropositive for HIV-1. Subjects were classified at their baseline evaluation as neuropsychologically (NP) normal or abnormal (impaired in > or = 2 NP test domains). A subgroup of NP abnormal subjects met operational criteria for HIV-associated minor cognitive motor disorder; the remaining subjects were designated NP impaired. Subjects with frank dementia were excluded. Mortality. At the baseline evaluation, 256 (62%) of 414 subjects were designated normal; 109 (26%). NP impaired; and 49 (12%), minor cognitive motor disorder. One hundred six participants (26%) died during follow-up. Compared with the NP normal group, the unadjusted relative risk (RR) of death for all NP abnormal subjects (minor cognitive motor disorder and NP impaired) was significantly increased (RR, 1.7; 95% confidence interval [CI], 1.2-2.6; P < .005). After adjusting for concurrently measured predictors of survival (CD4 lymphocyte counts, Centers for Disease Control and Prevention HIV disease classification, hemoglobin concentration, and serum beta 2-microglobulin) in proportional hazards models, mortality for all NP abnormal subjects remained elevated (RR, 1.8; 95% CI, 1.2-2.8; P < .01). The elevation in mortality risk for subjects with minor cognitive motor disorder was statistically significant (RR, 2.2; 95% CI, 1.2-3.8; P < .01); for NP impaired subjects it was marginally significant (RR, 1.6; 95% CI, 1.0-2.8; P = .06). The HIV-infected individuals with NP impairment had a higher risk of dying than those without impairment. This was particularly true for those meeting syndromic diagnostic criteria.

MeSH Terms
Adult Cognition Disorders/epidemiology,etiology Cohort Studies Dementia/epidemiology,etiology Female HIV Infections/complications,epidemiology,mortality HIV-1 Humans Male Nervous System Diseases/epidemiology,etiology Proportional Hazards Models Risk Factors
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Ellis R J
Department of Neurosciences, University of California, Department of Medicine, San Diego, USA. roellis@ucsd.edu
Deutsch R
Heaton R K
Marcotte T D
McCutchan J A
Nelson J A
Abramson I
Thal L J
Atkinson J H
Wallace M R
Grant I
Article Info
Journal
Archives of neurology
Abbr.
Arch Neurol
ISSN
0003-9942
Published
1997-04-00
Pages
416-24
Language
English
Region
United States
NLM ID
0372436
Subset
IM
Grants
NIMH NIH HHS · P50 MH 45294 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com